Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Project Inform perspective

Showing results (31-40 of 280) with videos related to

Pageof 28
Sort By:
Project Inform Perspective|May 22, 2001
Marketing scam spoils hep C treatment
Project Inform Perspective|May 22, 2001
Interleukin-2 (IL-2, Proleukin)
Project Inform Perspective|May 22, 2001
Mycophenylate - a potential new option
Project Inform Perspective|May 22, 2001
PHS guidelines on opportunistic infections. US Public Health Service
Project Inform Perspective|May 22, 2001
Medicaid managed care: a system in transition
Project Inform Perspective|May 22, 2001
Strategies for protease inhibitor failure
Project Inform Perspective|May 22, 2001
The science and marketing of simpler dosing
Project Inform Perspective|May 22, 2001
Update on antivirals
Project Inform Perspective|March 22, 2003
Anti-HIV drug updates--three drugs on the near horizon
Project Inform Perspective|March 22, 2003
New hope from new classes of therapy
Pageof 28

Showing results (31-40 of 280) with videos related to

Sort By:
Pageof 28
Project Inform Perspective|May 22, 2001
Marketing scam spoils hep C treatment
Project Inform Perspective|May 22, 2001
Interleukin-2 (IL-2, Proleukin)
Project Inform Perspective|May 22, 2001
Mycophenylate - a potential new option
Project Inform Perspective|May 22, 2001
PHS guidelines on opportunistic infections. US Public Health Service
Project Inform Perspective|May 22, 2001
Medicaid managed care: a system in transition
Project Inform Perspective|May 22, 2001
Strategies for protease inhibitor failure
Project Inform Perspective|May 22, 2001
The science and marketing of simpler dosing
Project Inform Perspective|May 22, 2001
Update on antivirals
Project Inform Perspective|March 22, 2003
Anti-HIV drug updates--three drugs on the near horizon
Project Inform Perspective|March 22, 2003
New hope from new classes of therapy
Pageof 28